JHancock Multifactor Technology ETF

Most Recent

Healthcare
Precision Medicine Oncology Pipeline Is Key for Kura Oncology
Kura Oncology (KURA) is a clinical-stage biopharmaceutical company focused on advancing its research pipeline of precision medicine.

By Margaret PatrickSep. 25 2018, Published 10:47 a.m. ET

ABOUT Market Realist
About Us
Privacy Policy
Terms of Use
DMCA

CONNECT with Market Realist

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.

JHancock Multifactor Technology ETF

Precision Medicine Oncology Pipeline Is Key for Kura Oncology